When did ALBIREO PHARMA INC (ALBO) report earnings last quarter?
ALBIREO PHARMA INC (ALBO) last reported earnings on 2/27/2023.
ALBIREO PHARMA INC (ALBO) Earnings History & Surprises
NASDAQ:ALBO • US01345P1066
Current stock price
44.15 USD
-0.1 (-0.23%)
At close:
44.33 USD
+0.18 (+0.41%)
After Hours:
ALBO Earnings overview
Past quarterly earnings results for ALBIREO PHARMA INC (ALBO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 15, 2023
- Period
- Q4 / 2022
- EPS Estimate
- -$2.01
- Revenue Estimate
- 10.038M
Last Reported
Most Recent- Release Date
- Feb 27, 2023
- Period
- Q3 / 2022
- EPS Reported
- -$1.92
- EPS Surprise
- -78.30%
- Revenue Surprise
- 0.99%
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2022 | -1.92 | -1.08 | -78.30% | 4.95% | 9.832M | 9.736M | 0.99% | 168.34% |
| Q2 2022 | -2.04 | -1.68 | -21.09% | -7.37% | 8.206M | 7.604M | 7.92% | 237.97% |
| Q1 2022 | -2.19 | -1.89 | -15.85% | 4.37% | 6.832M | 8.122M | -15.88% | 246.80% |
| Q4 2021 | -0.57 | -1.38 | 58.61% | 56.15% | 32.521M | 12.734M | 155.39% | 1,095.63% |
| Q3 2021 | -2.02 | -0.39 | -421.16% | -3.06% | 3.664M | 3.555M | 3.07% | 72.02% |
| Q2 2021 | -1.90 | -2.01 | 5.32% | -37.68% | 2.428M | 2.018M | 20.32% | 27.12% |
| Q1 2021 | -2.29 | -1.80 | -27.11% | -2.69% | 1.97M | 2.177M | -9.51% | 27.10% |
| Q4 2020 | -1.30 | -1.98 | 34.35% | - | 2.72M | 2.392M | 13.71% | - |
| Q3 2020 | -1.96 | -1.54 | -27.26% | - | 2.13M | 1.658M | 28.47% | - |
| Q2 2020 | -1.38 | -1.72 | 19.89% | - | 1.91M | 1.306M | 46.25% | - |
| Q1 2020 | -2.23 | -1.39 | -60.17% | - | 1.55M | 1.054M | 47.06% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-14.16%
Max EPS beat (4)
58.61%
Min EPS beat (4)
-78.30%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
37.10%
Max Revenue beat (4)
155.39%
Min Revenue beat (4)
-15.88%
Analysis
In the last 4 quarters, ALBO has beaten EPS estimates in 1 out of 4 releases
ALBO has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, ALBO reported -14.2% below the EPS estimates on average.
In the last 4 quarters, ALBO has beaten the revenue estimates by 37.1% on average.
Related analysis
ALBIREO PHARMA INC / ALBO Earnings FAQ
Did ALBIREO PHARMA INC (ALBO) beat earnings estimates last quarter?
ALBIREO PHARMA INC (ALBO) missed EPS estimates and beat revenue estimates in the most recent quarter.
How often does ALBIREO PHARMA INC (ALBO) beat earnings estimates?
In the last 4 quarters, ALBIREO PHARMA INC (ALBO) has beaten EPS estimates in 1 out of 4 releases.